A review of Cushing’s disease treatment by the Department of Neuroendocrinology of the Brazilian Society of Endocrinology and Metabolism

Detalhes bibliográficos
Autor(a) principal: Machado, Márcio Carlos
Data de Publicação: 2018
Outros Autores: Fragoso, Maria Candida Barisson Villares, Moreira, Ayrton Custódio, Boguszewski, Cesar Luiz, Vieira Neto, Leonardo, Naves, Luciana Ansaneli, Vilar, Lucio, Araújo, Luiz Antônio de, Musolino, Nina R. de C., Miranda, Paulo Augusto, Czepielewski, Mauro Antonio, Gadelha, Mônica Roberto, Bronstein, Marcello D., Oliveira Junior, Antonio Ribeiro de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFRGS
Texto Completo: http://hdl.handle.net/10183/195777
Resumo: The treatment objectives for a patient with Cushing’s disease (CD) are remission of hypercortisolism, adequate management of co-morbidities, restoration of the hypothalamic-pituitary-adrenal axis, preservation of fertility and pituitary function, and improvement of visual defects in cases of macroadenomas with suprasellar extension. Transsphenoidal pituitary surgery is the main treatment option for the majority of cases, even in macroadenomas with low probability of remission. In cases of surgical failure, another subsequent pituitary surgery might be indicated in cases with persistent tumor imaging at post surgical magnetic resonance imaging (MRI) and/or pathology analysis of adrenocorticotropic hormone-positive (ACTH+) positive pituitary adenoma in the first procedure. Medical treatment, radiotherapy and adrenalectomy are the other options when transsphenoidal pituitary surgery fails.There are several options of medical treatment, although cabergoline and ketoconazole are the most commonly used alone or in combination. Novel treatments are also addressed in this review. Different therapeutic approaches are frequently needed on an individual basis, both before and, particularly, after surgery, and they should be individualized. The objective of the present review is to provide the necessary information to achieve a more effective treatment for CD. It is recommended that patients with CD be followed at tertiary care centers with experience in treating this condition.
id UFRGS-2_0f8990a5535b4b279d9b5759044af9b7
oai_identifier_str oai:www.lume.ufrgs.br:10183/195777
network_acronym_str UFRGS-2
network_name_str Repositório Institucional da UFRGS
repository_id_str
spelling Machado, Márcio CarlosFragoso, Maria Candida Barisson VillaresMoreira, Ayrton CustódioBoguszewski, Cesar LuizVieira Neto, LeonardoNaves, Luciana AnsaneliVilar, LucioAraújo, Luiz Antônio deMusolino, Nina R. de C.Miranda, Paulo AugustoCzepielewski, Mauro AntonioGadelha, Mônica RobertoBronstein, Marcello D.Oliveira Junior, Antonio Ribeiro de2019-06-14T02:30:51Z20182359-4292http://hdl.handle.net/10183/195777001095516The treatment objectives for a patient with Cushing’s disease (CD) are remission of hypercortisolism, adequate management of co-morbidities, restoration of the hypothalamic-pituitary-adrenal axis, preservation of fertility and pituitary function, and improvement of visual defects in cases of macroadenomas with suprasellar extension. Transsphenoidal pituitary surgery is the main treatment option for the majority of cases, even in macroadenomas with low probability of remission. In cases of surgical failure, another subsequent pituitary surgery might be indicated in cases with persistent tumor imaging at post surgical magnetic resonance imaging (MRI) and/or pathology analysis of adrenocorticotropic hormone-positive (ACTH+) positive pituitary adenoma in the first procedure. Medical treatment, radiotherapy and adrenalectomy are the other options when transsphenoidal pituitary surgery fails.There are several options of medical treatment, although cabergoline and ketoconazole are the most commonly used alone or in combination. Novel treatments are also addressed in this review. Different therapeutic approaches are frequently needed on an individual basis, both before and, particularly, after surgery, and they should be individualized. The objective of the present review is to provide the necessary information to achieve a more effective treatment for CD. It is recommended that patients with CD be followed at tertiary care centers with experience in treating this condition.application/pdfengArchives of endocrinology and metabolism. São Paulo. Vol. 62, no. 1 (2018), p. 87-105.Síndrome de CushingRevisãoTerapêuticaBrasilSociedade Brasileira de Endocrinologia e MetabologiaCushing’s diseaseCushing’s syndromeTreatmentBrazilA review of Cushing’s disease treatment by the Department of Neuroendocrinology of the Brazilian Society of Endocrinology and Metabolisminfo:eu-repo/semantics/articleinfo:eu-repo/semantics/otherinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001095516.pdf.txt001095516.pdf.txtExtracted Texttext/plain100245http://www.lume.ufrgs.br/bitstream/10183/195777/2/001095516.pdf.txt91f859b35f378af0b917841c42411c82MD52ORIGINAL001095516.pdfTexto completo (inglês)application/pdf362857http://www.lume.ufrgs.br/bitstream/10183/195777/1/001095516.pdf00827eec5b908f74f6e4c69526d1312aMD5110183/1957772022-08-11 04:40:44.052138oai:www.lume.ufrgs.br:10183/195777Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2022-08-11T07:40:44Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.pt_BR.fl_str_mv A review of Cushing’s disease treatment by the Department of Neuroendocrinology of the Brazilian Society of Endocrinology and Metabolism
title A review of Cushing’s disease treatment by the Department of Neuroendocrinology of the Brazilian Society of Endocrinology and Metabolism
spellingShingle A review of Cushing’s disease treatment by the Department of Neuroendocrinology of the Brazilian Society of Endocrinology and Metabolism
Machado, Márcio Carlos
Síndrome de Cushing
Revisão
Terapêutica
Brasil
Sociedade Brasileira de Endocrinologia e Metabologia
Cushing’s disease
Cushing’s syndrome
Treatment
Brazil
title_short A review of Cushing’s disease treatment by the Department of Neuroendocrinology of the Brazilian Society of Endocrinology and Metabolism
title_full A review of Cushing’s disease treatment by the Department of Neuroendocrinology of the Brazilian Society of Endocrinology and Metabolism
title_fullStr A review of Cushing’s disease treatment by the Department of Neuroendocrinology of the Brazilian Society of Endocrinology and Metabolism
title_full_unstemmed A review of Cushing’s disease treatment by the Department of Neuroendocrinology of the Brazilian Society of Endocrinology and Metabolism
title_sort A review of Cushing’s disease treatment by the Department of Neuroendocrinology of the Brazilian Society of Endocrinology and Metabolism
author Machado, Márcio Carlos
author_facet Machado, Márcio Carlos
Fragoso, Maria Candida Barisson Villares
Moreira, Ayrton Custódio
Boguszewski, Cesar Luiz
Vieira Neto, Leonardo
Naves, Luciana Ansaneli
Vilar, Lucio
Araújo, Luiz Antônio de
Musolino, Nina R. de C.
Miranda, Paulo Augusto
Czepielewski, Mauro Antonio
Gadelha, Mônica Roberto
Bronstein, Marcello D.
Oliveira Junior, Antonio Ribeiro de
author_role author
author2 Fragoso, Maria Candida Barisson Villares
Moreira, Ayrton Custódio
Boguszewski, Cesar Luiz
Vieira Neto, Leonardo
Naves, Luciana Ansaneli
Vilar, Lucio
Araújo, Luiz Antônio de
Musolino, Nina R. de C.
Miranda, Paulo Augusto
Czepielewski, Mauro Antonio
Gadelha, Mônica Roberto
Bronstein, Marcello D.
Oliveira Junior, Antonio Ribeiro de
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Machado, Márcio Carlos
Fragoso, Maria Candida Barisson Villares
Moreira, Ayrton Custódio
Boguszewski, Cesar Luiz
Vieira Neto, Leonardo
Naves, Luciana Ansaneli
Vilar, Lucio
Araújo, Luiz Antônio de
Musolino, Nina R. de C.
Miranda, Paulo Augusto
Czepielewski, Mauro Antonio
Gadelha, Mônica Roberto
Bronstein, Marcello D.
Oliveira Junior, Antonio Ribeiro de
dc.subject.por.fl_str_mv Síndrome de Cushing
Revisão
Terapêutica
Brasil
Sociedade Brasileira de Endocrinologia e Metabologia
topic Síndrome de Cushing
Revisão
Terapêutica
Brasil
Sociedade Brasileira de Endocrinologia e Metabologia
Cushing’s disease
Cushing’s syndrome
Treatment
Brazil
dc.subject.eng.fl_str_mv Cushing’s disease
Cushing’s syndrome
Treatment
Brazil
description The treatment objectives for a patient with Cushing’s disease (CD) are remission of hypercortisolism, adequate management of co-morbidities, restoration of the hypothalamic-pituitary-adrenal axis, preservation of fertility and pituitary function, and improvement of visual defects in cases of macroadenomas with suprasellar extension. Transsphenoidal pituitary surgery is the main treatment option for the majority of cases, even in macroadenomas with low probability of remission. In cases of surgical failure, another subsequent pituitary surgery might be indicated in cases with persistent tumor imaging at post surgical magnetic resonance imaging (MRI) and/or pathology analysis of adrenocorticotropic hormone-positive (ACTH+) positive pituitary adenoma in the first procedure. Medical treatment, radiotherapy and adrenalectomy are the other options when transsphenoidal pituitary surgery fails.There are several options of medical treatment, although cabergoline and ketoconazole are the most commonly used alone or in combination. Novel treatments are also addressed in this review. Different therapeutic approaches are frequently needed on an individual basis, both before and, particularly, after surgery, and they should be individualized. The objective of the present review is to provide the necessary information to achieve a more effective treatment for CD. It is recommended that patients with CD be followed at tertiary care centers with experience in treating this condition.
publishDate 2018
dc.date.issued.fl_str_mv 2018
dc.date.accessioned.fl_str_mv 2019-06-14T02:30:51Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/other
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10183/195777
dc.identifier.issn.pt_BR.fl_str_mv 2359-4292
dc.identifier.nrb.pt_BR.fl_str_mv 001095516
identifier_str_mv 2359-4292
001095516
url http://hdl.handle.net/10183/195777
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Archives of endocrinology and metabolism. São Paulo. Vol. 62, no. 1 (2018), p. 87-105.
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRGS
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Repositório Institucional da UFRGS
collection Repositório Institucional da UFRGS
bitstream.url.fl_str_mv http://www.lume.ufrgs.br/bitstream/10183/195777/2/001095516.pdf.txt
http://www.lume.ufrgs.br/bitstream/10183/195777/1/001095516.pdf
bitstream.checksum.fl_str_mv 91f859b35f378af0b917841c42411c82
00827eec5b908f74f6e4c69526d1312a
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv
_version_ 1801224968601600000